Expert Radar
Dr. Michael Thirman, MD
Dr. Michael Thirman, MD
Co-Program Leader, University of Chicago Medicine Comprehensive Cancer Center
Doctor of Medicine, University of Michigan Medical School
Dr. Michael J. Thirman has over 28 years of experience in the field of Hematology and Oncology. He earned his BA in Biomedical Sciences from the University of Michigan and his MD from the University of Michigan Medical School. After completing his residency in Internal Medicine at M Health Fairview University of Minnesota Medical Center - West Bank Hospital, he went on to complete a fellowship in Clinical Pharmacology at Minneapolis VA Medical Center and in Hematology and Oncology at University of Chicago Medical Center. Today, this expert is board certified in Internal Medicine. Formerly, this expert held roles as an Assistant Professor of the Section of Hematology/Oncology at the University of Chicago and as the Co-Program Leader of Hematopoiesis and Hematologic Malignancies at the University of Chicago Comprehensive Cancer Center. Currently, he serves as a Physician at UChicago Medicine Duchossois Center for Advanced Medicine and as an Associate Professor of Medicine at the University of Chicago. He also serves as the Director of Leukemia Biology at the University of Chicago.
m*********@******.edu
(773) ***-****
Chicago, Illinois
Get a FREE Demo of Dr. Michael Thirman, MD's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
Radar Metrics At A Glance
Expert Witness Activity
17
Plaintiff Cases
Defense Cases
15
Expert Challenges
3
Deposition Transcripts
Publications
85
Media & News
225
Social Media Mentions
Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.
Expert Witness Activity
Radar found 18 records
Case Name | Role | Filed Date |
|---|---|---|
Kevin Wright vs Union Oil Company of California, et al. | Expert Witness | 2021-03-08 |
Celegene Corporation v. Apotex, Inc. | Expert Witness | 2019-02-26 |
Acrotech Biopharma, LLC, et al. v. Fresenius Kabi USA, LLC, et al. | Expert Witness | 2018-10-03 |
Radar monitors both national and state court systems to track litigation activity and access court documents.
View case details, documents, plaintiff and defense representation, defendants, judges, jurisdiction, and more.
Litigation Analytics
Retained By
Defense
Plaintiff
Activity over time
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
Activity by state
Case Outcome
0
25
50
75
100
Publications
Radar found 85 records
Title | Type |
|---|---|
Clinical and Molecular Response of AML Harboring Non-Canonical FLT3 N676k Driver Mutations to Contemporary FLT3 Inhibitors | Journal Article |
Pathobiology of Acute Myeloid Leukemia | Book Chapter |
Apoptosis Induction and Growth Suppression By U19/Eaf2 Is Mediated Through Its ELL-Binding Domain | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Media & News
Radar found 225 records
Title | Description |
|---|---|
Clinical Trial Will Evaluate Novel 3-Drug Regimen for First- ... | Mar 4, 2024 -- Cancer specialists want to know whether combining these 3 agents can lead to greater efficacy in the treatment of patients with CLL. This ... |
bims-tremyl 2024-02-18 papers | Feb 18, 2024 ----- Keith W Pratz, Brian A Jonas, Vinod Pullarkat, Michael J Thirman ... annual meeting . Xubo Gong, Xin He, Lin Wang, Teng Yu, Weiwei Liu ... |
Comprehensive care improves outcomes in adult ... | Jan 16, 2024 -- A new study shows that comprehensive treatment of acute lymphoblastic leukemia improves outcomes and reduces the negative impact of ... |
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
Education
Institution | Degree Type |
|---|---|
University of Michigan Medical School | Doctor of Medicine |
University of Michigan | Bachelor of Arts |
Work History
Title | Employer |
|---|---|
Co-Program Leader | University of Chicago Medicine Comprehensive Cancer Center |
Director | University of Chicago Medicine |
Associate Professor of Medicine | University of Chicago Medicine |
What to expect from a Radar profile
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 5–7 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.
